Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307)
- Citation:
- J Clin Oncol vol 25 (18s) abstr 7707
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 885
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- P. A. Janne X. F. Wang L. M. Krug L. Hodgson E. E. Vokes H. L. Kindler
- Networks:
- Study
- CALGB-30307
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: